artículo académico

• Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Tria.  Journal of the National Cancer Institute.  112:1030-1037. 2020
• Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study.  Journal of Infectious Diseases.  2020
• Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials.  Journal of the National Cancer Institute.  112:818-828. 2020
• Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial.  Journal of the National Cancer Institute.  112:1038-1046. 2020
• Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines.  Vaccine.  38:5997-6006. 2020
• Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.  Journal of the National Cancer Institute.  110:205-212. 2018
• Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies.  Vaccine.  36:4774-4782. 2018
• The Natural History of Oral Human Papillomavirus in Young Costa Rican Women.  Sexually Transmitted Diseases.  44:442-449. 2017
• Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.  American Journal of Obstetrics and Gynecology.  215:212.e1-212.e15. 2016
• Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.  American Journal of Obstetrics and Gynecology.  215:212.e1-212.e15. 2016
• Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.  Journal of the National Cancer Institute.  108. 2015
• Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.  Vaccine.  33:2141-2151. 2015